4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000899243-22-036016
Chief Commercial Officer sold 4,254 shares at $60.06 ($255,495)
- Chief Commercial Officer acquired 4,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Khayal Tamer I Chief Commercial Officer | 2022-11-15 | Option exercise | +4,254 | $2.21 | $9,401 | 5,554 | D: show line 1 in the form |
| Khayal Tamer I Chief Commercial Officer | 2022-11-15 | Sale | −4,254 | $60.06 | $255,495 | 1,300 | D: show line 2 in the form |
| Open-market sales · 4,254 sh · avg $60.06 · $255,495 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Khayal Tamer I Chief Commercial Officer | 2022-11-15 | Option exercise · Stock Option (Right to Buy) | −4,254 | 11,051 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…